Agency Forms Undergoing Paperwork Reduction Act Review, 51807-51808 [2012-21030]
Download as PDF
<![CDATA[
51807
Federal Register / Vol. 77, No. 166 / Monday, August 27, 2012 / Notices
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The American Recovery and
Reinvestment Act of 2009 (ARRA)
allotted $650 million to the Department
of Health and Human Services (HHS) to
support evidence-based prevention and
wellness strategies. The cornerstone of
the initiative is the Communities
Putting Prevention to Work (CPPW)
Community Program, administered by
the Centers for Disease Control and
Prevention (CDC). In March 2010, HHS
made 44 CPPW awards for communitybased obesity and tobacco preventions
efforts, followed in September 2010 by
additional awards made possible by
Affordable Care Act (ACA) funding.
Between the two funding sources, there
are 50 communities that are part of
CPPW: 28 are funded only for obesityrelated initiatives; 11 are funded for
both obesity and tobacco initiatives; and
11 are funded only for tobacco-related
initiatives.
CPPW program efforts are supported
by a National Prevention Media
Initiative. Although originally planned
as a national campaign, CDC determined
that the best support for the CPPW
communities would be to shift to a
localized approach. CDC plans to
conduct two cycles of information
collection in the 39 target communities
that are addressing obesity: the first in
Fall 2012 and the second in Winter/
Spring 2013. The target is 6,000
completed responses for each cycle of
data collection. A separate sample will
be drawn for each of the 39
communities. All information will be
collected through brief telephone
interviews with adults aged 25 years or
older. The insights to be gained from
this information collection will be
valuable to assessing the impact of
CPPW-related program activities. The
information will specifically be used to
assess aided and unaided awareness of
CPPW media efforts, beliefs and
attitudes about obesity, and behaviors
that encourage active eating and healthy
living. Results will be used to inform
the design and delivery of future media
campaigns.
OMB approval is requested for one
year. The estimated burden per response
is one minute or less for eligibility
screening, five minutes for an
incomplete telephone interview, and 10
minutes for a complete telephone
interview. Participation in the telephone
interviews is voluntary and there are no
costs to respondents other than their
time. The total estimated annualized
burden hours are 2,406.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Adult General Public ≥25 years of age ..........
Screener for the Community Telephone
Interview.
Community Telephone Interview (incomplete)
Community Telephone Interview (complete)
Dated: August 21, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
comments should be received within 30
days of this notice.
Proposed Project
Minimum Data Elements (MDEs) for
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
(OMB No. 0920–0571, exp. 11/30/
2012)—Extension—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2012–21033 Filed 8–24–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day-12–0571]
pmangrum on DSK3VPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
VerDate Mar<15>2010
15:04 Aug 24, 2012
Jkt 226001
Background and Brief Description
Many cancer-related deaths in women
could be avoided by increased
utilization of appropriate screening and
early detection tests for breast and
cervical cancer. Mammography is
extremely valuable as an early detection
tool because it can detect breast cancer
well before the woman can feel the
lump, when the cancer is still in an
early and more treatable stage.
Similarly, a substantial proportion of
cervical cancer-related deaths could be
prevented through the detection and
treatment of precancerous lesions. The
Papanicolaou (Pap) test is the primary
method of detecting both precancerous
cervical lesions as well as invasive
cervical cancer. Mammography and Pap
tests are underused by women who have
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
Average
burden per
response
(in hr)
22,400
1
1/60
400
12,000
1
1
5/60
10/60
no source or no regular source of health
care and women without health
insurance.
The CDC’s National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP) provides screening services
to underserved women through
cooperative agreements with 50 States,
the District of Columbia, 5 U.S.
Territories, and 11 American Indian/
Alaska Native tribal programs. The
program was established in response to
the Breast and Cervical Cancer Mortality
Prevention Act of 1990. Screening
services include clinical breast
examinations, mammograms and Pap
tests, as well as timely and adequate
diagnostic testing for abnormal results,
and referrals to treatment for cancers
detected. NBCCEDP awardees collect
patient-level screening and tracking data
to manage the program and clinical
services. A de-identified subset of data
on patient demographics, screening tests
and outcomes are reported by each
awardee to CDC twice per year.
CDC is requesting OMB approval to
collect MDE information for an
additional three years. CDC anticipates
a reduction in the overall burden
estimate due to a decrease in the
number of awardees from 68 to 67.
E:\FR\FM\27AUN1.SGM
27AUN1
51808
Federal Register / Vol. 77, No. 166 / Monday, August 27, 2012 / Notices
There are no changes to the currently
approved minimum data elements,
electronic data collection procedures, or
the estimated burden per response.
Because NBCCEDP awardees already
collect and aggregate data at the state,
territory and tribal level, the additional
burden of submitting data to CDC will
be modest. CDC will use the information
to monitor and evaluate NBCCEDP
awardees; improve the availability and
quality of screening and diagnostic
services for underserved women;
develop outreach strategies for women
who are never or rarely screened for
breast and cervical cancer, and report
program results to Congress and other
legislative authorities.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
536.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
NBCCEDP Awardees .....................................
Minimum Data Elements ................................
67
2
4
Dated: August 21, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science,
Office of the Directors, Centers for Disease
Control and Prevention.
[FR Doc. 2012–21030 Filed 8–24–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day-12–0824]
Agency Forms Undergoing Paperwork
Reduction Act Review
pmangrum on DSK3VPTVN1PROD with NOTICES
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
BioSense 2.0 Recruitment of Data
Sources (OMB No. 920–0824, exp. 10/
31/2012)—Revision—Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS), Public
Health Surveillance and Informatics
Program Office (PHSIPO) {Proposed}
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002,
VerDate Mar<15>2010
15:04 Aug 24, 2012
Jkt 226001
and it was launched by the Centers for
Disease Control and Prevention (CDC) in
2003. BioSense is a near real-time
surveillance system that receives and
processes electronic healthcare
encounter data from participating public
health jurisdictions’ non-federal
hospital emergency departments and
inpatient facilities in addition to all
United States Department of Defense
(DoD) and Veterans Affairs (VA)
outpatient hospitals and clinics
nationwide. The BioSense Program also
receives pharmacy data from a private
sector health information exchange firm
and laboratory data from two nationallevel private sector clinical laboratories.
The BioSense Program is in the
process of transitioning from the
original BioSense application to the
BioSense 2.0 application that has new
governance, a new organizational
structure, and a new process for data
submission and management. The
Association of State and Territorial
Health Officials (ASTHO) has been
funded through a cooperative agreement
with CDC’s Division of Notifiable
Disease and Healthcare Information
(DNDHI) within the Public Health
Surveillance and Informatics Program
Office (PHSIPO) of the Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS) to facilitate
the governance of BioSense 2.0, and
through a contract with a vendor,
ASTHO will offer access and use of
BioSense 2.0 on a voluntary basis to
state, local, and territorial public health
jurisdictions.
All data collected by BioSense 2.0
will reside in a cloud-enabled, Webbased platform that sits in the secure,
private Government Cloud and is in
compliance with the Federal
Information Security Management Act.
The platform will provide users with an
exclusive secure space as well as tools
for posting, receiving, controlling,
analyzing, and sharing their public
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
health surveillance information with
other public health jurisdictions, CDC,
or other public health partners. The
public health jurisdiction will retain
ownership of any data it contributes to
its exclusive secure space within
BioSense 2.0.
CDC has agreements with VA, DoD,
two national-level private sector clinical
laboratories, and a private sector health
information exchange firm to provide
healthcare encounter data to CDC’s
exclusive secure space for the purpose
of national public health situation
awareness and syndromic surveillance.
These organizations automatically chose
to share with CDC when they were
recruited to submit data to the BioSense
2.0 cloud environment. Because they are
not required to choose sharing
permissions, collecting already existing
healthcare encounter data submitted via
electronic record transmission from
them entails no burden hours.
Whenever possible, the BioSense
Program plans to share aggregate-level
pharmacy and laboratory data with
public health jurisdictions in the shared
space. To participate in the shared
space, jurisdiction administrators must
simply select from drop-down lists to
choose their sharing permissions on the
BioSense 2.0 application, and they will
have the right at any time to revise the
level of sharing permissions regarding
the data in their secure space.
In order to continue meeting the
congressional mandate in the BioSense
2.0 application BioSense Program
maintains 3 different types of
information collection: (1) contact
information (name, telephone number,
email address, and street address)
needed for recruitment of participating
public health jurisdictions to BioSense
2.0 each year; (2) one-time collection of
information (name, email address, title,
organizational affiliation, security
questions, and password) to provide
access to the BioSense 2.0 cloud and its
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 77, Number 166 (Monday, August 27, 2012)]
[Notices]
[Pages 51807-51808]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-21030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-12-0571]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Minimum Data Elements (MDEs) for the National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) (OMB No. 0920-0571, exp. 11/
30/2012)--Extension--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Many cancer-related deaths in women could be avoided by increased
utilization of appropriate screening and early detection tests for
breast and cervical cancer. Mammography is extremely valuable as an
early detection tool because it can detect breast cancer well before
the woman can feel the lump, when the cancer is still in an early and
more treatable stage. Similarly, a substantial proportion of cervical
cancer-related deaths could be prevented through the detection and
treatment of precancerous lesions. The Papanicolaou (Pap) test is the
primary method of detecting both precancerous cervical lesions as well
as invasive cervical cancer. Mammography and Pap tests are underused by
women who have no source or no regular source of health care and women
without health insurance.
The CDC's National Breast and Cervical Cancer Early Detection
Program (NBCCEDP) provides screening services to underserved women
through cooperative agreements with 50 States, the District of
Columbia, 5 U.S. Territories, and 11 American Indian/Alaska Native
tribal programs. The program was established in response to the Breast
and Cervical Cancer Mortality Prevention Act of 1990. Screening
services include clinical breast examinations, mammograms and Pap
tests, as well as timely and adequate diagnostic testing for abnormal
results, and referrals to treatment for cancers detected. NBCCEDP
awardees collect patient-level screening and tracking data to manage
the program and clinical services. A de-identified subset of data on
patient demographics, screening tests and outcomes are reported by each
awardee to CDC twice per year.
CDC is requesting OMB approval to collect MDE information for an
additional three years. CDC anticipates a reduction in the overall
burden estimate due to a decrease in the number of awardees from 68 to
67.
[[Page 51808]]
There are no changes to the currently approved minimum data elements,
electronic data collection procedures, or the estimated burden per
response. Because NBCCEDP awardees already collect and aggregate data
at the state, territory and tribal level, the additional burden of
submitting data to CDC will be modest. CDC will use the information to
monitor and evaluate NBCCEDP awardees; improve the availability and
quality of screening and diagnostic services for underserved women;
develop outreach strategies for women who are never or rarely screened
for breast and cervical cancer, and report program results to Congress
and other legislative authorities.
There are no costs to respondents other than their time. The total
estimated annualized burden hours are 536.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees.................. Minimum Data Elements.... 67 2 4
----------------------------------------------------------------------------------------------------------------
Dated: August 21, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science, Office of the Directors, Centers for Disease
Control and Prevention.
[FR Doc. 2012-21030 Filed 8-24-12; 8:45 am]
BILLING CODE 4163-18-P
